A high-stakes North American legal battle—centering on a politically connected Sikh-Canadian businessman at the collision point of Canada's regulated cannabis sector and what U.S. authorities call a "multiyear, multinational attack" on American markets—and two estranged Vancouver brothers, one a convicted heroin trafficker and the other a cannabis cultivator alleging he was cut out of a Health Canada–licensed venture—has taken a turn in B.C. Supreme Court.
In one action, Emerald Health Sciences and related parties—including former British Columbia physician Avtar Singh Dhillon—have denied allegations by Krishansarup "Kris" Kallu, an estranged relative who says the company was structured to enrich insiders later charged by the U.S. government and to conceal key investors with deep narcotics ties that extend to chemical-precursor labs in Pakistan's northern mountains—including his brother, Yadvinder "Yad" Kallu.
Dhillon—a British Columbia–educated physician and Sikh community leader now based in California—has long displayed deep political proximity in Canada; among the images circulating online is a photo of his niece with Prime Minister Justin Trudeau.
As Emerald Health stepped back from Dr. Dhillon—later drawn into an SEC case describing his role, along with West Vancouver lawyer Fred Sharp, in a one-billion-dollar stock-fraud network as a "multiyear, multinational attack" on American markets—his former Emerald partners filed a civil indemnity claim in September 2025 to create legal distance from Yadvinder Kallu.
Read more at The Bureau